Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Danguole Altman
AddedMar 31, 2024
UpdatedMay 31, 2026
Danguole Altman

Danguole Altman

CEO, Cx Precision Medicine

CrunchbaseLinkedIn

Danguole Altman's Career

Cx Precision Medicine
Cx Precision Medicine

Fort Worth, TX, US

CEO· C-Suite · Management
Vapogenix
Vapogenix

Houston, TX, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Danguole Altman's Career

Cx Precision Medicine
Cx Precision Medicine
Pre-Seed$1.8M72016Fort Worth, TX, US
CEO· C-Suite · Management

Leadership at Cx Precision Medicine

Sid O’BryantSid O’BryantFounder
Vapogenix
Vapogenix
Series B$21.6M82006Houston, TX, US
Founder

Leadership at Vapogenix

Heather Giles PhD, FBPharmacolSHeather Giles PhD, FBPharmacolSCEO

Similar to Vapogenix

Concentric AnalgesicsConcentric AnalgesicsSan Francisco, CA, USTherapeuticsest. 2014Concentric AnalgesicsSan Francisco, CA, US · est. 2014

Concentric Analgesics, Inc.: A biotech firm innovating non-opioid solutions for acute and chronic pain.

Series B · $103.1M22
Phoenix PharmaLabsPhoenix PharmaLabsWoods Cross, UT, USAddiction Treatment, Pain Reliefest. 2002Phoenix PharmaLabsWoods Cross, UT, US · est. 2002

Phoenix PharmaLabs: A clinical-stage company developing non-addictive pain relief and opiate addiction treatments.

Series A · $13.6M14
Regulonix HoldingRegulonix HoldingTucson, AZ, USPain Treatmentsest. 2017Regulonix HoldingTucson, AZ, US · est. 2017

Regulonix: A biotech firm innovating non-opioid, chronic pain treatments via NaV1.7 channel targeting.

Seed · $2M8
VapocoolshotVapocoolshotBoca Raton, FL, USMedical Devicesest. 2020VapocoolshotBoca Raton, FL, US · est. 2020

Vapocoolshot: Innovating pain and anxiety reduction technology since 2020, based in Florida.

Angel · $250k3

People Similar to Danguole Altman

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoSteven WaltherSteven WaltherCo-Founder · Continuous Precision MedicineSeulki LeeSeulki LeeCo-Founder & CEO · D&D PharmatechWayne BrinsterWayne BrinsterCEO · PreciseDxTarek Ali ZakiTarek Ali ZakiCo-Founder · OncoPrecisionKarl WassmanKarl WassmanCEO · Source Precision Medicine